The oral preparation workshop passed the US FDA certification with zero defects

The oral preparation workshop passed the US FDA certification with zero defects

Yichang Humanwell Pharmaceutical Co., Ltd. is pleased to announce the US Food and Drug Administration (FDA) has completed successful Post Approval inspection of its affiliated Oral Solid Dosage manufacturing facility, Yichang Humanwell Oral Solid Dosage Plant, located in Yichang, Hubei Province China. The inspection demonstrated that the site is compliant with Current Good Manufacturing Practices, and no Form 483 observations were issued. This FDA inspection took place on June 20 through June 24 2016.